SecBot SecBot
8-K ·Filed Jun 10, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed5mo ago SEC0001493152-26-028106
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

The investor presentation is a routine corporate update with no new material information. Monitor for future SEC filings containing clinical pipeline updates, financial results, or regulatory catalysts for the pz-cel program.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$5.53
T+0 close · Jun 10, 2026 · via day close
Latest settled
+28.75%
T+20 · $7.12
Vs SPY
+26.86%
α at T+20
Next horizon
T+60
due 2mo ago
  1. T+0 · Jun 11 $5.53entry
  2. T+1 · 5mo ago 0.00%α −0.54% · $5.53
  3. T+5 · 5mo ago +2.17%α +1.74% · $5.65
  4. T+20 · 4mo ago +28.75%α +26.86% · $7.12
  5. T+60 · due 2mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Abeona Therapeutics filed an 8-K furnishing an updated investor presentation (Exhibit 99.1) under Item 7.01 for use in meetings with investors and analysts. No material financial data, guidance updates, or business developments were disclosed, this is a routine disclosure of a corporate presentation used for investor relations.

Key Facts

  • Filed an 8-K on June 10, 2026 furnishing an updated investor presentation under Item 7.01.
  • The presentation is dated June 10, 2026 and is attached as Exhibit 99.1.
  • No financial results, guidance, material agreements, or operational updates were disclosed.
  • The filing is a routine Regulation FD disclosure for use in investor meetings.

Financial Impact

No financial impact, no material financial data or guidance was provided.

Risk Factors

  • No material information disclosed, the presentation may contain forward-looking statements with standard risk factors.
  • Biotech sector risks including clinical trial setbacks, regulatory delays, and capital needs.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-028106
Document: 0001493152-26-028106-index-headers.html0001493152-26-028106
Document: 0001493152-26-028106-index.html0001493152-26-028106
Document: 0001493152-26-028106.txt0001493152-26-028106

Track record

29 reports on ABEO

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026